Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Tobira Therapeutics Inc buy Quitte

Tobira Therapeutics Inc
Start price
€8.66
21.12.15 / 50%
Target price
€9.92
21.06.16
Performance (%)
18.02%
End price
€10.22
21.06.16
Summary
This prediction ended on 21.06.16 with a price of €10.22. The BUY prediction by Quitte finished with a performance of 18.02%. Quitte has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Tobira Therapeutics Inc - - - -
iShares Core DAX® -1.059% 5.007% 6.596% 64.713%
iShares Nasdaq 100 -2.387% 0.864% 25.791% 88.244%
iShares Nikkei 225® -4.361% 1.211% 41.309% 79.311%
iShares S&P 500 -1.778% 1.391% 21.037% 69.603%

Comments by Quitte for this prediction

In the thread Tobira Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 18.02%
Target price 9.922
Change
Ends at 21.06.16

aussichtsreicher Kandidat

Cenicriviroc ist ein aussichtsreicher Kandidat.

beruhigend: 68 Mio Cash und eine Marktkapitalisierung von 174 Mio 

Quitte 
0
Report Share
21.12.15
Prediction Buy
Perf. (%) 18.02%
Target price 9.922
Change
Ends at 21.06.16

(Laufzeit überschritten)

Quitte 
0
Report Share
21.06.16

Stopped prediction by Quitte for Tobira Therapeutics Inc

buy
Tobira Therapeutics Inc

Start price
Target price
Perf. (%)
€10.82
23.06.16
€11.73
02.12.16
250.75%
02.12.16

Quitte 
21.08.19 50%
buy
Tobira Therapeutics Inc

Start price
Target price
Perf. (%)
€12.18
27.08.15
€12.50
21.09.15
2.93%
21.09.15

Quitte 
21.08.19 50%